| Name | Title | Contact Details |
|---|
Sunrise Medical Technology is a Waxahachie, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ambulatory care at Hotel Dieu Hospital (HDH) is specialized care that may include a scheduled visit to one or more hospital clinics, diagnostic or procedural areas. In some cases, a single health care professional, for example a surgeon or internal medicine physician, may see patients in a traditional clinic setting. Increasingly, patients and families will receive care in a team-based inter-disciplinary and/or inter-professional program, such as our pre-surgical screening, diabetes, breast assessment, bariatric, chronic pain or cardiac rehabilitation programs. Ambulatory care at HDH includes care for patients with urgent and less critical emergency problems at our Urgent Care Centre. Hotel Dieu Hospital has a very active ambulatory surgery program where most patients return home the same day. We also have a short-stay facility in the form of a satellite post-anesthetic care unit that supports patients who need extended time for pain control and rehabilitation therapy. This facility is key to our innovative fast-track total hip and knee arthroplasty program. Hotel Dieu Hospital is a faith-based, academic hospital where research and learning take place every day and where we are committed to partnership with patients and families. We actively engage in implementing innovative models of care that support patient care, as well as regional and academic health care needs. Affiliated with Queen`s University, we serve as a major teaching location for learners from across the Faculty of Health Sciences, including medical, nursing and allied health learners. And research at Hotel Dieu Hospital contributes to the growing field of knowledge about health care and ambulatory care in Canada and beyond. Ambulatory care at Hotel Dieu Hospital is part of an integrated, cost-effective system of health care in Southeastern Ontario.
Aqueduct Medical is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MCRA is the leading global full-service medical device, diagnostics, and biologics CRO and consulting advisory firm. MCRA delivers to its client`s industry experience, integrating its six business value creators: regulatory, clinical research, reimbursement, healthcare compliance, quality assurance, and distribution logistics to provide a dynamic, market-leading effort from innovation conception to commercialization. MCRA`s integrated application of these key value-creating initiatives provides unparalleled value for its clients. MCRA has offices in Washington, DC, Hartford, CT, New York, NY, and Tokyo, Japan and serves nearly 1,000 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, biologics, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, anesthesia, general surgery, digital health, neurology, robotics, oncology, general and plastic surgery, urology, and in vitro diagnostic (IVD) devices and medical device cybersecurity. MCRA places particular emphasis on its expertise working with companies in all stages of development and throughout the technology life cycle by ushering technologies from the conceptual pre-clinical stage to market approval.
Bone Biologics was founded by University of California Los Angeles professors in collaboration with an Osaka University professor, and a USC surgeon in 2004. Formed to pursue regenerative medicine for bone, the company currently has as its strategic partners the Musculoskeletal Transplant Foundation, the nation's leading tissue bank and Orthofix, a leading global medical device company. Bone Biologics is currently focused on bone regeneration in spinal fusion using its recombinant human protein known as Nell-1. Nell-1 is an osteoinductive orthobiologic; a recombinant protein that provides control over bone regeneration. This patent protected technology has been exclusively licensed to Bone Biologics from UCLA.